Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: for

Sample Size Calculation for Parallel Group Studies – Clinical Trial Design and Protocol Development

Posted on June 8, 2025 digi By digi

Sample Size Calculation for Parallel Group Studies – Clinical Trial Design and Protocol Development “Calculating Sample Size for Parallel Group Research” Introduction to Sample Size Calculation for Parallel Group Studies Sample size calculation is a critical step in the planning of clinical trials, including parallel group studies. The sample size has a significant impact on…

Read More “Sample Size Calculation for Parallel Group Studies – Clinical Trial Design and Protocol Development” »

Clinical Trial Design and Protocol Development, Parallel Group Designs

Operational Planning for Seamless Phase Transitions – Clinical Trial Design and Protocol Development

Posted on June 5, 2025 digi By digi

Operational Planning for Seamless Phase Transitions – Clinical Trial Design and Protocol Development “Efficient Operational Planning for Smooth Phase Changes” Introduction to Operational Planning in Clinical Studies Operational planning for seamless phase transitions in clinical studies is a critical process that ensures the smooth progression of a clinical trial from one phase to another. This…

Read More “Operational Planning for Seamless Phase Transitions – Clinical Trial Design and Protocol Development” »

Adaptive Trial Designs, Clinical Trial Design and Protocol Development

Ethical Justification for Adaptive Modifications – Clinical Trial Design and Protocol Development

Posted on June 4, 2025 digi By digi

Ethical Justification for Adaptive Modifications – Clinical Trial Design and Protocol Development “Moral Grounds for Adaptive Changes” Introduction In clinical research, adaptive modifications have become an increasingly significant tool. These modifications make a trial more flexible and efficient, potentially improving the delivered outcomes for patients. However, their implementation is not without ethical considerations. This article…

Read More “Ethical Justification for Adaptive Modifications – Clinical Trial Design and Protocol Development” »

Adaptive Trial Designs, Clinical Trial Design and Protocol Development

Regulatory Expectations for RCT Designs – Clinical Trial Design and Protocol Development

Posted on June 3, 2025 digi By digi

Regulatory Expectations for RCT Designs – Clinical Trial Design and Protocol Development “Guidelines for Designing Randomized Controlled Trials” Introduction Randomized Controlled Trials (RCTs) are fundamental in the clinical research sector, offering a robust method for evaluating the efficacy and safety of new medical interventions. However, the design and execution of these trials must adhere to…

Read More “Regulatory Expectations for RCT Designs – Clinical Trial Design and Protocol Development” »

Clinical Trial Design and Protocol Development, Randomized Controlled Trials (RCTs)

Sample Size Determination for RCTs – Clinical Trial Design and Protocol Development

Posted on June 3, 2025 digi By digi

Sample Size Determination for RCTs – Clinical Trial Design and Protocol Development “Determining the Sample Size for Randomized Controlled Trials” Introduction to Sample Size Determination for RCTs Randomized Controlled Trials (RCTs) are a cornerstone of clinical research, providing the gold standard for evaluating the efficacy of new treatments. A critical aspect of designing any RCT…

Read More “Sample Size Determination for RCTs – Clinical Trial Design and Protocol Development” »

Clinical Trial Design and Protocol Development, Randomized Controlled Trials (RCTs)

Designing a Parallel RCT for Drug Efficacy Testing – Clinical Trial Design and Protocol Development

Posted on June 2, 2025 digi By digi

Designing a Parallel RCT for Drug Efficacy Testing – Clinical Trial Design and Protocol Development “Creating a Parallel Randomized Controlled Trial for Testing Drug Effectiveness” Introduction Randomized Controlled Trials (RCTs) are considered the gold standard in medical research due to their ability to eliminate bias and provide unbiased results. A Parallel RCT is a type…

Read More “Designing a Parallel RCT for Drug Efficacy Testing – Clinical Trial Design and Protocol Development” »

Clinical Trial Design and Protocol Development, Randomized Controlled Trials (RCTs)

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
    • U.S. FDA Regulations
    • CDSCO (India) Guidelines
    • EMA (European Medicines Agency) Guidelines
    • PMDA (Japan) Guidelines
    • MHRA (UK) Guidelines
    • TGA (Australia) Guidelines
    • Health Canada Guidelines
    • WHO Guidelines
    • ICH Guidelines
    • ASEAN Guidelines
  • Clinical Trial Design and Protocol Development
    • Randomized Controlled Trials (RCTs)
    • Adaptive Trial Designs
    • Crossover Trials
    • Parallel Group Designs
    • Factorial Designs
    • Cluster Randomized Trials
    • Single-Arm Trials
    • Open-Label Studies
    • Blinded Studies (Single, Double, Triple)
    • Non-Inferiority and Equivalence Trials
    • Randomization Techniques in Crossover Trials
  • Good Clinical Practice (GCP) and Compliance
    • GCP Training Programs
    • ICH-GCP Compliance
    • GCP Violations and Audit Responses
    • Monitoring Plans
    • Investigator Responsibilities
    • Sponsor Responsibilities
    • Ethics Committee Roles

Menu

Recent Posts

  • Examples of Parallel Designs in Oncology Trials – Clinical Trial Design and Protocol Development
  • Impact of Cultural and Linguistic Validation in Multinational Phase 3 Trials: Ensuring Data Quality and Global Compliance
  • Phase 1 Study Designs for Cell and Gene Therapies
  • Drug Utilization Studies and Physician Practice Patterns in Phase 4
  • Strategies for Managing High Screen Failure Rates in Phase 3 Trials: Practical Approaches to Optimize Enrollment

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme